When I Had to Ask the Question the System Should Have Asked

I’m not anti-doctor.
I’m not anti-medicine.
And I’m not someone who walks into an appointment assuming I know more than the person on the other side of the desk.

But I am someone who pays attention and does his own research.

At a routine appointment, my blood work came back with one number circled: LDL cholesterol — high. The recommendation followed quickly and confidently: statins.

What stopped me wasn’t stubbornness — it was confusion.

Because everything else told a very different story. My triglycerides were low. My HDL was high. Those two numbers, taken together, usually point toward good metabolic health and lower cardiovascular risk. The pattern didn’t match the concern.

So I did what most people don’t do in that moment. I went home and did some quick research.

And that’s when I discovered something that surprised even me.

LDL is not one thing.

LDL particles come in different sizes. Large, buoyant LDL particles are far less likely to penetrate artery walls. Small, dense LDL particles are the ones strongly associated with plaque formation and cardiovascular disease. Two people can have the exact same LDL number and completely different risk profiles.

That distinction is not controversial. It’s not fringe. It’s been well documented for years.

Even more striking? People with low triglycerides and high HDL — like me — overwhelmingly tend to have the larger, less harmful LDL pattern. In other words, my overall lipid profile pointed in the opposite direction of what the single LDL number suggested.

That’s when the thought hit me:

If this matters — and it clearly does — why wasn’t it part of the conversation?

So at the next visit, I asked a question that surprised even me:

“Can we check LDL particle size?”

Not because I wanted to challenge anyone.
Not because I was trying to avoid treatment.
But because I wanted confirmation before committing to a lifelong medication — when every other marker suggested low risk.

The response wasn’t pushback. It was something quieter. Surprise that I even knew to ask.

And that’s the part that stuck with me.

Modern medicine isn’t built around patterns — it’s built around thresholds. If LDL crosses a line on a chart, the algorithm says to act. It’s efficient. It’s defensible. It protects against worst-case outcomes. But it also ignores nuance — and biology is nuance.

Statins absolutely save lives when used appropriately. No question. But using them as a reflex instead of a targeted tool comes with real consequences: muscle pain, fatigue, metabolic effects, and the subtle message that something is wrong with you when it isn’t.

What bothers me isn’t my outcome. I advocated for myself and got clarity.

What bothers me is how many people never realize there was more to the story.

How many people are put on statins simply because LDL was elevated — even when their triglycerides are low, HDL is high, blood sugar is stable, inflammation is low, and arteries are healthy?

The sad truth is the why.

This isn’t happening because doctors are careless. It’s happening because the system rewards simplicity over precision. Because guidelines lag behind evidence. Because advanced testing is labeled “optional” to keep medicine tidy — even when human biology isn’t.

And because it’s easier to prescribe than to explain.

That’s what I find sad.

Not that statins exist — but that too many people are placed on them without ever being shown the full picture of their own health.